NCT05369897

Brief Summary

The main objective of the study is to investigate the effects of using a set of Virtual Reality (VR)-based Digital Therapeutics (DTx) apps to improve the cognitive abilities of healthy (high-functioning) seniors. For the purposes of the study, high-functioning seniors are defined as being over the age of 65 years, while maintaining their functional independence with regards to activities of daily living, including the ability to go on a long walk and the ability to interact with common modern technology (e.g. using a smartphone to send a message). The study focuses on improving the quality of life of older healthy people by facilitating cognitive training through VR. Healthy people aged 65-85 will be eligible for the project. If the participants meet the inclusion criteria, they will be invited to participate in the study and be provided with detailed information about the research project. Based on sample size calculations, up to two hundred (200) older adults are intended to be included in the project. The participants will use specially designed VR systems and activities aimed at improving their cognitive abilities.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2022

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 21, 2022

Completed
9 days until next milestone

Study Start

First participant enrolled

April 30, 2022

Completed
11 days until next milestone

First Posted

Study publicly available on registry

May 11, 2022

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2023

Completed
Last Updated

July 6, 2022

Status Verified

June 1, 2022

Enrollment Period

1.1 years

First QC Date

April 21, 2022

Last Update Submit

June 30, 2022

Conditions

Outcome Measures

Primary Outcomes (2)

  • Working memory

    Assessed with the "Working Memory" domain from the CNS Vital Signs (CNSVS) computerized neuropsychological battery. The range of scores is from 0 to 38, with higher scores indicating better performance. A positive change after the intervention corresponds to an improvement in performace from baseline to follow-up.

    Change in scores between pre-intervention (baseline) and post-intervention (after 3 months).

  • Attention

    Assessed with the "Complex Attention" domain from the CNS Vital Signs (CNSVS) computerized neuropsychological battery. The range of scores is from 0 to 76, with higher scores indicating better performance. A positive change after the intervention corresponds to an improvement in performace from baseline to follow-up.

    Change in scores between pre-intervention (baseline) and post-intervention (after 3 months).

Secondary Outcomes (5)

  • Cognitive functioning

    Change in scores between pre-intervention (baseline) and post-intervention (after 3 months).

  • Standard grip strength measurement using a dynamometer

    Change in scores between pre-intervention (baseline) and post-intervention (after 3 months).

  • The quality of life and the level of perceived well-being

    Change in scores between pre-intervention (baseline) and post-intervention (after 3 months).

  • Severity of anxiety symptoms

    Change in scores between pre-intervention (baseline) and post-intervention (after 3 months).

  • Health-related quality of life

    Change in scores between pre-intervention (baseline) and post-intervention (after 3 months).

Study Arms (2)

VR training

EXPERIMENTAL

VR training for at least 10 minutes at least three days per week, resulting in a total of at least 36 sessions (at least \~12 hours of training in total) for each participant, spread across three months. Each session will focus on cognitive training.

Device: VR training

VR activity

SHAM COMPARATOR

VR activity for at least 10 minutes at least three days per week, resulting in a total of at least 36 sessions (at least \~12 hours of training in total) for each participant, spread across three months, with 360º images and videos but without the interactive cognitive training.

Device: VR activity

Interventions

The intervention group will receive cognitive training through VR headsets three times a week for 12 weeks. The intervention will be delivered in a virtual setting using images and music. The participants will be allowed to select the type of music and virtual environment during the intervention. The intervention will include four modules targeting attention and working memory through immersive VR.

VR training

High-quality 360º images and videos from natural environments, such as a relaxing mountain environment. The participants in the control group will not receive cognitive training.

VR activity

Eligibility Criteria

Age65 Years - 85 Years
Sexall
Healthy VolunteersYes
Age GroupsOlder Adult (65+)

You may qualify if:

  • Healthy or in a stable medical condition
  • Undisturbed locomotion
  • Do not require care or help from others in their everyday functioning
  • Are able to go on long walks unassisted
  • Are able to use common modern technology unassisted (e.g. using a smartphone to send a message)

You may not qualify if:

  • Presence of neuropsychiatric disorders, including mild cognitive impairment (MCI) - Montreal Cognitive Assessment (MoCA) score \<26 points
  • Abuse or addiction to alcohol, drugs and tranquilizers
  • Blurred vision that cannot be corrected with lenses or glasses that fit under the VR headset
  • Auditory pathologies causing a significant decrease in hearing unaided
  • High sensitivity to motion sickness
  • Proneness to migraines
  • Subject epileptic
  • Subject vulnerable
  • Subject obese or frail, as assessed based on their Body Mass Index (BMI)
  • Subject considered by the study investigator to be an unsuitable candidate to participate in the study, due to other relevant reasons

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Old Age Psychiatry and Psychotic Disorders Medical University of Lodz

Lodz, 92-213, Poland

RECRUITING

Related Publications (2)

  • Szczepocka E, Mokros L, Kazmierski J, Nowakowska K, Lucka A, Antoszczyk A, Oltra-Cucarella J, Werzowa W, Hellevik MM, Skouras S, Bagger K. The Effectiveness of Virtual Reality-Based Training on Cognitive, Social, and Physical Functioning in High-Functioning Older Adults (CoSoPhy FX): 2-Arm, Parallel-Group Randomized Controlled Trial. JMIR Res Protoc. 2024 Jun 5;13:e53261. doi: 10.2196/53261.

  • Szczepocka E, Mokros L, Kazmierski J, Nowakowska K, Lucka A, Antoszczyk A, Oltra-Cucarella J, Werzowa W, Hellevik M, Skouras S, Bagger K. Virtual reality-based training may improve visual memory and some aspects of sustained attention among healthy older adults - preliminary results of a randomized controlled study. BMC Psychiatry. 2024 May 8;24(1):347. doi: 10.1186/s12888-024-05811-2.

Study Officials

  • Jakub M Kaźmierski, PhD

    Medical University of Lodz, Poland

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Jakub M Kaźmierski, PhD

CONTACT

Ewa Ł Szczepocka, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
The participants will be randomly assigned to either the experimental or the control group, and will be blind to the group assignment. The data gathered before and after the intervention will be sent to an external statistical analyst blinded to group assignment.
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assoc. Prof. MD, PhD

Study Record Dates

First Submitted

April 21, 2022

First Posted

May 11, 2022

Study Start

April 30, 2022

Primary Completion

June 1, 2023

Study Completion

June 1, 2023

Last Updated

July 6, 2022

Record last verified: 2022-06

Data Sharing

IPD Sharing
Will share

Once the first publication is publicly accessible, the anonymous data generated will be made available for sharing upon request. Shared data will include demographics, primary and secondary outcomes, and VR usability data. A committee of experts within the study team will discuss and decide whether data sharing is appropriate, based on the novelty and scientific rigor of the proposal. Applicants will be asked to sign a data access agreement to ensure a commitment to using the data only for research purposes and to securing the data with appropriate procedures. Redistribution of the data to other third parties will not be allowed.

Time Frame
Data will become available after the first publication. There is no time restriction for sharing the data.
Access Criteria
Through formal application. Applicants will be asked to sign a data access agreement to ensure a commitment to using the data only for research purposes and to securing the data with appropriate procedures.

Locations